PAMS
KRON

Pictet Asset Management (Switzerland)’s Kronos Bio KRON Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-183,099
Closed -$3.84M – 1774
2021
Q3 		$3.84M Buy
+183,099
New +$3.93M ﹤0.01% 892

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s KRON Position: Q4 2021 in Review

Pictet Asset Management (Switzerland) sold out of Kronos Bio (KRON) in Q4 2021, closing a stake of 183,099 shares — an estimated $3.84M sold.

Pictet Asset Management (Switzerland) first reported a position in KRON in Q3 2021 and held it in 1 quarter. The position peaked at $3.84M in Q3 2021. 81 funds tracked by Wall St. Rank hold KRON as of Q4 2021.

  • Pictet Asset Management (Switzerland) reported no remaining Kronos Bio position as of Q4 2021 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 183,099 Kronos Bio shares in Q4 2021, an estimated $3.84M.
  • Pictet Asset Management (Switzerland) first reported a position in Kronos Bio in Q3 2021 and held it in 1 quarter.
  • Pictet Asset Management (Switzerland)'s Kronos Bio position peaked at $3.84M in Q3 2021.
  • 81 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2021.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 10 Feb 2022.